Journal of Dermatological Treatment

Title Publication Date Language Citations
A quantitative definition of severe psoriasis for use in clinical trials2004/01/01English67
Long‐term safety and tolerability of pimecrolimus cream 1% and topical corticosteroids in adults with moderate to severe atopic dermatitis2004/06/01English66
Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 22019/06/09English64
Psoriasis disease severity measures: comparing efficacy of treatments for severe psoriasis2003/09/01English63
Glutathione as an oral whitening agent: A randomized, double-blind, placebo-controlled study2010/06/05English63
Teledermatology: a useful tool to fight COVID-192020/04/13English63
Drug survival of biologic treatments in psoriasis: a systematic review2017/11/10English63
An effective, cosmetically acceptable, novel hydro-gel emollient for the management of dry skin conditions2002/01/01English62
Applications of platelet-rich plasma in dermatology: A critical appraisal of the literature2015/10/14English61
Treatment of seborrheic dermatitis: a comprehensive review2018/05/24English61
Role of oral tranexamic acid in melasma patients treated with IPL and low fluence QS Nd:YAG laser2011/12/27English61
Adalimumab treatment is associated with improvement in health‐related quality of life in psoriasis: Patient‐reported outcomes from a Phase II randomized controlled trial2007/01/01English61
Improvement of skin barrier function in atopic dermatitis patients with a new moisturizer containing a ceramide precursor2012/09/19English60
Efficacy of sodium hypochlorite (bleach) baths to reduceStaphylococcus aureuscolonization in childhood onset moderate-to-severe eczema: A randomized, placebo-controlled cross-over trial2015/08/13English60
Pustulosis palmoplantaris is a disease distinct from psoriasis2010/08/05English59
Review of 26 cases of classical pyoderma gangrenosum: clinical and therapeutic features2004/06/01English59
JAK/STAT inhibitors for the treatment of atopic dermatitis2019/02/18English59
The efficacy and safety of 5α-reductase inhibitors in androgenetic alopecia: a network meta-analysis and benefit–risk assessment of finasteride and dutasteride2013/07/05English59
Clinical characteristics of psoriatic arthritis and psoriasis in dermatologists' offices2006/01/01English58
Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis2019/10/28English58
A randomized, double-blind, placebo-controlled, dose-escalation study of the safety and efficacy of INCB039110, an oral janus kinase 1 inhibitor, in patients with stable, chronic plaque psoriasis2016/01/14English58
Total skin clearance results in improvements in health-related quality of life and reduced symptom severity among patients with moderate to severe psoriasis2014/07/31English58
Hidradenitis suppurativa treated with dapsone: A case series of five patients2006/01/01English57
Real-world practice indirect comparison between guselkumab, risankizumab, and tildrakizumab: results from an Italian 28-week retrospective study2022/05/29English56
Minoxidil: a comprehensive review2021/07/20English56
The potential role of cannabinoids in dermatology2019/10/10English56
Melasma and its impact on health‐related quality of life in Hispanic women2007/01/01English56
The efficacy and safety of etanercept when used with as-needed adjunctive topical therapy in a randomised, double-blind study in subjects with moderate-to-severe psoriasis (the PRISTINE trial)2012/02/23English55
Systematic review of machine learning for diagnosis and prognosis in dermatology2019/10/31English55
Biologic fatigue in psoriasis2013/08/27English54